Investors knew ahead of the Nov. 6 arrival of Puma Biotechnology's (PBYI +0.22%) third-quarter update that the report was going to be an important one. The question on everyone's mind was pretty ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results